Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 1, 2025

Conditions
Univentricular HeartMicrovascular DysfunctionHeart FailureMagnetic Resonance
Interventions
DIAGNOSTIC_TEST

Cardiac magnetic resonance stress-perfusion

"Included patients will be examined at the Karolinska University Hospital in a 1.5T Siemens Sola magnetic resonance camera at rest and during adenosine stress with specific CMR sequences (adenosine stress-perfusion, myocardial velocities, and tissue characterization) for non-invasive determination of macro- and microvascular dysfunction, global myocardial function, pulmonary artery pressure and scarring of the myocardium.~Adenosine or Regadenoson will be used as stress medication which is according to clinical routine. Adenosine will be infused over approximately 5 minutes (110-140 μg / kg/min), Regadenoson (5 ml) will be a 10-second injection (400 μg single dosage). Intravenous gadolinium-based contrast agents will be administered, Gadovist (1 mmol/ml, gadobuterol), 0.15 mmol/kg during stress and rest."

Trial Locations (1)

17176

RECRUITING

Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Karolinska Institutet

OTHER